ICMR clinical trial finds convalescent plasma therapy against COVID-19 to be ineffective

plasma therapy
  • The trials called PLACID Trials were conducted between 22nd April and 14th July at 39 centres across the country. 
  • There was not any significant difference in mortality rates between those who received convalescent plasma therapy and those in the control group.
Share on facebook
Share on twitter
Share on telegram